Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Income from Continuing Operations (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Income from Continuing Operations for 2 consecutive years, with 15109000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 69.65% to 15109000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 55480000.0 through Dec 2025, down 255.0% year-over-year, with the annual reading at 55480000.0 for FY2025, 255.0% down from the prior year.
  • Income from Continuing Operations hit 15109000.0 in Q4 2025 for Connect Biopharma Holdings, up from 17200000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 14847000.0 in Q2 2024 to a low of 17200000.0 in Q3 2025.